Log In
Print
BCIQ
Print
Print this Print this
 

VT-1161

  Manage Alerts
Collapse Summary General Information
Company Viamet Pharmaceuticals Inc.
DescriptionSmall molecule metalloenzyme inhibitor of cytochrome P450 C-14 alpha demethylase (CYP51)
Molecular Target Cytochrome P450 C-14 alpha demethylase (CYP51)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationFungal infection
Indication DetailsTreat acute vulvovaginal candidiasis; Treat fungal infections; Treat moderate to severe interdigital tinea pedis; Treat onychomycosis
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today